Author

Kevin C. Entzminger

ORCID 0000-0001-8167-9585Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alex Samadi· 1 shared Jonathan K. Fleming· 1 shared Lisa Yuko EspinosaiD· 1 shared Paul D. Entzminger· 1 shared Shigeru C.J. Okumura· 1 shared Toshiaki MaruyamaiD· 1 shared Yuko Hiramoto· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Alex Samadi

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Engineering a pH-sensitive humanized infliximab with improved potency and developability using STEM™

Paul D. Entzminger, Kevin C. Entzminger, Jonathan K. Fleming, Alex Samadi, Lisa Yuko Espinosa, Yuko Hiramoto, Shigeru C.J. Okumura, Toshiaki Maruyama

This study humanizes and engineers infliximab to improve its potency and developability, identifying LW2Y as a lead candidate with enhanced pH-dependent properties.

bioRxiv · Aug 19, 2026 · PreprintBioengineering